Peg-Interferon



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Hepatitis C 71.4%
Insomnia 8.6%
Pain 5.7%
Pregnancy 5.7%
Sinus Congestion 5.7%
Osteoarthritis 2.9%
Toxic Encephalopathy 25.0%
Aphagia 8.3%
Eczema 8.3%
Hepatitis C 8.3%
Liver Transplant Rejection 8.3%
Maternal Drugs Affecting Foetus 8.3%
Tachycardia 8.3%
Thrombocytopenia 8.3%
Thrombotic Thrombocytopenic Purpura 8.3%
Vomiting 8.3%
Secondary
Hepatitis C 65.1%
Product Used For Unknown Indication 16.4%
Chronic Hepatitis C 3.7%
Hiv Infection 3.7%
Hepatitis 2.3%
Stomatitis 1.7%
Hypertension 1.2%
Urinary Tract Infection 1.2%
Depression 0.6%
Nausea 0.6%
Neutropenia 0.6%
Seasonal Affective Disorder 0.6%
Affect Lability 0.3%
Alopecia 0.3%
Anaemia 0.3%
Antiviral Treatment 0.3%
Autoimmune Thyroiditis 0.3%
Cheilitis 0.3%
Drug Dependence 0.3%
Dry Skin 0.3%
Rash 24.6%
Skin Reaction 6.6%
Vomiting 6.6%
White Blood Cell Count Decreased 6.6%
Neutropenia 4.9%
Thrombocytopenia 4.9%
Acute Generalised Exanthematous Pustulosis 3.3%
Drug Reaction With Eosinophilia And Systemic Symptoms 3.3%
Oral Pain 3.3%
Pneumonia 3.3%
Pruritus 3.3%
Psychotic Disorder 3.3%
Pyrexia 3.3%
Rash Generalised 3.3%
Rectal Haemorrhage 3.3%
Staphylococcal Sepsis 3.3%
Steatorrhoea 3.3%
Toxic Skin Eruption 3.3%
Urinary Tract Infection 3.3%
Viraemia 3.3%
Concomitant
Hepatitis C 77.4%
Product Used For Unknown Indication 9.1%
Hiv Infection 4.8%
Chronic Hepatitis C 2.4%
Drug Use For Unknown Indication 1.9%
Hypertension 1.0%
Anaemia 0.5%
Anticoagulant Therapy 0.5%
Atrial Fibrillation 0.5%
Depression 0.5%
Hepatic Cirrhosis 0.5%
Hepatitis 0.5%
Hypothyroidism 0.5%
Rash 36.4%
Thrombocytopenia 13.6%
Skin Reaction 4.5%
Toxic Skin Eruption 4.5%
Vomiting 4.5%
White Blood Cell Count Decreased 4.5%
Anaemia 2.3%
Angina Pectoris 2.3%
Blood Creatinine Increased 2.3%
Blood Disorder 2.3%
Bursitis 2.3%
Cholecystitis 2.3%
Dysgeusia 2.3%
Haemorrhoids 2.3%
Hepatic Cirrhosis 2.3%
Hepatic Failure 2.3%
Hepatocellular Carcinoma 2.3%
Hyponatraemia 2.3%
Influenza Like Illness 2.3%
International Normalised Ratio Decreased 2.3%